Skip to content

Quadratus Lumborum Block Type 2 Versus Posterior Transversus Abdominus Plane Block

A Comparative Study Between Quadratus Lumborum Block Type 2 and Posterior Transversus Abdominus Plane Block for Analgesia After Cesarean Delivery Under Spinal Anesthesia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04773730
Acronym
quadratus
Enrollment
100
Registered
2021-02-26
Start date
2021-03-15
Completion date
2023-06-03
Last updated
2023-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Regional Block

Brief summary

This patient population are at risk of adverse effects secondary to inadequate pain management such as inadequate maternal bonding and late ambulation. Regional analgesia is preferred due to their opioid sparing effects and reduction in related adverse effects but the analgesia from these blocks is not known which one is superior to the other in the context of cesarean section

Detailed description

The aim of this study is to compare the effect of posterior transversus abdominus plane block and quadratus lumborum type 2 for cesarean delivery. The transversus abdominus plane(TAP) block provides sensory block from T6 to L1 for lower abdominal surgeries. Quadratous lumborum type 2 block, the injection is posterior to the quadratus lumborum muscle. This method has the advantage of a more superficial point of injection with better ultrasonographic resolution. Only one RCT was done in this context by Kalpana Verma and his colleagues comparing quadratus lumborum type 2 and posterior transversus abdominus plane block. That shows marked discrepancy with time to first analgesic request from the quadratus lumborum block in other abdominal surgeries

Interventions

PROCEDUREPosterior transversus abdominus plane block

Twenty mL of bupivacaine 0.25% will be injected in the plane between the transverses abdominus muscle and the fascia deep to the internal oblique muscle on each side

Twenty mL of bupivacaine 0.25% will be injected on the posterior surface of quadrates lumborum muscle on each side

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Masking description

pain score assessment will be done by an anesthetist who is not involved in randomization or in the anesthetic technique

Intervention model description

patients will be randomly allocated via sealed opaque envelop into 2 groups of 50 patients each; Posterior transversus abdominus block (TAP) group and Quadratus lumborum block type 2 is the second group (QLB)group

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists physical status II parturient. * Singleton pregnancies with a gestation of at least 37 weeks. * Patients undergoing spinal anesthesia for cesarean deliveryvia a Pfannenstiel incision with exteriorization of the uterus.

Exclusion criteria

* Age \< 19 or \> 40 years. * Height\<150 cm, weight \< 60 kg, body mass index (BMI) ≥35 kg/m2. * Inability to comprehend or participatein pain scoring system. * Contraindications to spinal anesthesia (Coagulopathy, increased intracranial pressure, or local skin infection). * Hypersensitivity to any drugused in the study. * Hypertensive disorders of pregnancy. * Renal impairment or other contraindication to non-steroidal anti-inflammatory drugs. * Significant cardiovascular, renal or hepatic abnormalities. * Patients with history of opoid intake, drug abusers, psychiatric patients.

Design outcomes

Primary

MeasureTime frameDescription
The analgesic durationwithin 24 hours after the surgerythe time measured from finishing the block till the first request of analgesia by the patient

Secondary

MeasureTime frameDescription
Postoperative pain on movement (attempted hip flexion) or coughingimmediately and 1,2,3,4hour at postanesthesia care unit, then in the surgical ward at 6,8,10,12,18 and 24 h100 centimetres visual analog scale (VAS) for pain, where zero is equal to no pain and hundred indicates the worst possible pain
Patient satisfaction24 hours after surgerypoor= 1, fair = 2, good = 3, excellent = 4
Heart rateat 1st, 2nd, 3rd, 4th, 10th, 16th and 22nd hours postoperativelybeat per minute
Postoperative pain at restimmediately and 1,2,3,4hour at postanesthesia care unit, then in the surgical ward at 6,8,10,12,18 and 24 h100 centimetres visual analog scale (VAS) for pain, where zero is equal to no pain and hundred indicates the worst possible pain
Total postoperative analgesic consumption of of ketolac, paracetamol and fentanylwithin the first 24 hours after surgeryPatients with visual analog scale more than 30 will receive 30 mg of intravenous ketolac in addition to 1gm paracetamol which will be repeated every 8 hours intravenous infusion of every 8 hours. Intravenous administration of fentanyl bolus doses of 0.5 µg per kg per dose will be given if the visual analog scale remains more than 30
Postoperative nausea and vomitingwithin 24 hours after surgery0= none, 1= mild, 2= moderate and 3= sever
Postoperative lower limb weaknesswithin 24 hours after surgeryreported by the patient during her first walk after surgery
Non-invasive blood pressureat 1st, 2nd, 3rd, 4th, 10th, 16th and 22nd hours postoperativelymmHg

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026